Solitude Financial Services’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
ETC
Solitude Financial Services's BMY Position: Q2 2026 in Review
Solitude Financial Services reduced its Bristol-Myers Squibb (BMY) stake by 30% in Q2 2026, selling an estimated $97.6K and leaving 3,910 shares worth $225K. The position accounts for 0.06% of the portfolio, ranked #39.
Solitude Financial Services first reported a position in BMY in Q1 2024 and has held it in 10 quarters since. The position peaked at $690K in Q1 2025. 878 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Solitude Financial Services held 3,910 shares of Bristol-Myers Squibb worth $225K as of Q2 2026.
- Solitude Financial Services sold 1,700 Bristol-Myers Squibb shares in Q2 2026, an estimated $97.6K.
- Bristol-Myers Squibb made up 0.06% of Solitude Financial Services's portfolio in Q2 2026, its #39 holding.
- Solitude Financial Services first reported a position in Bristol-Myers Squibb in Q1 2024 and has held it in 10 quarters since.
- Solitude Financial Services's Bristol-Myers Squibb position peaked at $690K in Q1 2025.
- 878 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Solitude Financial Services's 13F filing for Q2 2026, filed 24 Jul 2026.